Apixaban (Eliquis®) for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation
Apixaban (Eliquis®) for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Rapid Review
| Commenced | Completed | Outcome |
| 07/12/2012 | 21/12/2012 | Full Pharmacoeconomic Assessment Recommended |
Pharmacoeconomic Evaluation
| Commenced | Completed | Outcome |
| 05/04/2013 | 31/05/2013 | Reimbursement Recommended |